Products
Platform
Research
Market
Learn
Compare PGIM India Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.37 | 1.87 |
NAV | ₹9.89 | ₹40.45 |
Fund Started | 19 Nov 2024 | 25 Jun 2018 |
Fund Size | ₹104.81 Cr | ₹6226.82 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 90 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.37
1.87
NAV
₹9.89
₹40.45
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹104.81 Cr
₹6226.82 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | - | 4.06% |
3 Year | - | 27.90% |
5 Year | - | 20.00% |
1 Year
-
4.06%
3 Year
-
27.90%
5 Year
-
20.00%
Holding Analysis
Equity | 98.30% | 97.55% |
Cash | 0.08% | 2.45% |
Equity
98.30%
97.55%
Cash
0.08%
2.45%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.26% |
Divi's Laboratories Ltd. | 8.40% |
Max Healthcare Institute Ltd. | 7.40% |
Dr. Reddy's Laboratories Ltd. | 6.41% |
Aster DM Healthcare Ltd. | 6.09% |
Mankind Pharma Ltd. | 5.22% |
JB Chemicals & Pharmaceuticals Ltd. | 4.70% |
Krishna Institute of Medical Sciences Ltd | 3.91% |
Abbott India Ltd. | 3.32% |
Global Health Ltd. | 3.32% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.58% |
Dr. Reddy's Laboratories Ltd. | 9.10% |
Divi's Laboratories Ltd. | 8.75% |
Aurobindo Pharma Ltd. | 8.25% |
Cipla Ltd. | 6.92% |
Lupin Ltd. | 5.43% |
Alkem Laboratories Ltd. | 4.05% |
Biocon Ltd. | 3.11% |
Gland Pharma Ltd. | 2.97% |
Mankind Pharma Ltd. | 2.95% |
Fund Manager
Name | Vivek Sharma | Dharmesh Kakkad |
Start Date | 19 Nov 2024 | 23 Feb 2021 |
Name
Vivek Sharma
Dharmesh Kakkad
Start Date
19 Nov 2024
23 Feb 2021
About Fund
Description | The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 19 Nov 2024 | 25 Jun 2018 |
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018